Keay Nakae
Stock Analyst at Chardan Capital
(1.25)
# 1848
Out of 5,352 analysts
278
Total ratings
31.96%
Success rate
8.51%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SABS SAB Biotherapeutics | Maintains: Buy | 20 20 | 1.86 | 975.27% | 15 | May 15, 2025 | |
OBIO Orchestra BioMed Hld... | Maintains: Buy | 20 20 | 3.25 | 515.38% | 10 | May 13, 2025 | |
KRRO Korro Bio | Maintains: Buy | 25 25 | 11.95 | 109.21% | 2 | May 13, 2025 | |
COYA Coya Therapeutics | Maintains: Buy | 14 14 | 5.71 | 145.18% | 18 | May 13, 2025 | |
ARWR Arrowhead Pharma | Maintains: Buy | 60 60 | 16.61 | 261.23% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 50 | 13.27 | 276.79% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 65 | 34.43 | 88.79% | 16 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 35 | 5.33 | 556.66% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 2 6 | 7 | -14.29% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 5 | 0.84 | 495.24% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 300 325 | 303.68 | 7.02% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 1.16 | 1624.14% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2 | 200% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 5 | 3.44 | 45.35% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 2.87 | -12.89% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 1.78 | 124.72% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 0.8 | 900% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 6 | n/a | n/a | 6 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 5 | n/a | n/a | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 | n/a | n/a | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 8 6 | 10.57 | -43.24% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 8 | n/a | n/a | 5 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 50 | n/a | n/a | 4 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 20 | 0.5 | 3900% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 55 | 6.41 | 758.03% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 175 125 | n/a | n/a | 4 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 10 | 10.28 | -2.72% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 2 | n/a | n/a | 4 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 39 | n/a | n/a | 4 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 100 88 | 9.5 | 821.05% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1 13 | 0.85 | 1429.41% | 3 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 155 40 | 3.08 | 1198.7% | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Terminates Coverage On: Buy | 3 0 | n/a | n/a | 3 | May 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 70 | n/a | n/a | 2 | Mar 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22500 | n/a | n/a | 1 | Jun 2, 2017 |